Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial - Barco, S; Lankeit, M; Binder, H (Thromb Haemost, 2016)
, et al.